Your browser doesn't support javascript.
loading
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol, Joaquim; Laidlaw, Tanya M; Bachert, Claus; Mannent, Leda P; Canonica, G Walter; Han, Joseph K; Maspero, Jorge F; Picado, Cesar; Daizadeh, Nadia; Ortiz, Benjamin; Li, Yongtao; Ruddy, Marcella; Laws, Elizabeth; Amin, Nikhil.
Afiliación
  • Mullol J; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
  • Laidlaw TM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, USA.
  • Bachert C; Upper Airways Research Laboratory and Department of Otorhinolaryngology, Ghent University, Ghent, Belgium.
  • Mannent LP; Division of ENT Diseases, CLINTEX, Karolinska Institutet, Stockholm, Sweden.
  • Canonica GW; First Affiliated Hosptial, Sun Yat-sen University, Guangzhou, China.
  • Han JK; Global Clinical Development, Sanofi, Chilly-Mazarin, France.
  • Maspero JF; Department of Biomedical Sciences, Humanitas University, Personalized Medicine Asthma & Allergy Unit-IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Picado C; Department of Otolaryngology & Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.
  • Daizadeh N; Allergy and Respiratory Medicine, Fundación CIDEA, Buenos Aires, Argentina.
  • Ortiz B; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain.
  • Li Y; Biostatistics, Sanofi, Cambridge, Massachusetts, USA.
  • Ruddy M; Immunology and Allergy Medical Affairs, Regeneron Pharmaceuticals, Inc., New York, USA.
  • Laws E; Global Medical Affairs Respiratory, Sanofi, Bridgewater, New Jersey, USA.
  • Amin N; Clinical Sciences Global Development, Regeneron Pharmaceuticals, Inc., Tarrytown, New Jersey, USA.
Allergy ; 77(4): 1231-1244, 2022 04.
Article en En | MEDLINE | ID: mdl-34459002
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Respiratorios / Sinusitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Allergy Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos Respiratorios / Sinusitis / Pólipos Nasales / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adult / Humans Idioma: En Revista: Allergy Año: 2022 Tipo del documento: Article País de afiliación: España